Clinique pitches topical performance against lasers

9-Jun-2010

Serum claims wrinkle and DNA damage correction

Having used 4% hydroquinone as the benchmark for the activity of its Even Better Clinical Dark Spot Corrector, launched earlier this year, Estée Lauder brand Clinique is now pitching the performance of its technology against laser treatment. The company says that used twice a day for 12 weeks its new Repairwear Laser Focus Wrinkle & UV Damage Corrector can achieve 63% of the visible wrinkle reducing power of a laser.

Described as a de-ageing serum, the product contains a blend of three patented repair enzymes encapsulated in a liposome delivery system. Micrococcus luteus (Ultrasomes V) work best at night to intensify the skin’s ability to visibly repair UVB damage; photolyase fermentate (Photosomes V) absorbs visible light to promote natural cellular repair, working during the day to improve the appearance of sun damaged skin over time; and OGG-1 fermentate (Roxisomes), derived from the mustard plant, protect cells from oxidative damage caused by UV and intrinsic ageing. Together, the enzymes are said to visibly reverse UV damage and mend ‘solar scars’.

Meanwhile wrinkle reducing polypeptide technology – comprising whey protein, retinyl palmitate and acetyl hexapeptide-8 – is said to boost natural collagen production and help maintain existing natural collagen. Free radical protection is provided by vitamins C and E, ergothioneine and Punica grantum (pomegranate).

The serum suitable for all skin types and ages and is intended for application morning and night all over the face, including around the eye area.